Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811) 2025-09-24 19:45
1